؉ cells isolated from human umbilical cord blood ( 
Introduction
Human umbilical cord blood (HUCB) offers potential in a number of clinical applications including transplantation [1] [2] [3] due to the abundance of hematopoietic stem/progenitor cells in the CD34 ϩ cell population. 4, 5 The in vitro expansion of CD34 ϩ cells contained in HUCB is an attractive and useful method for hematopoietic reconstitution in recipients who fail to exhibit engrafting after transplantation of HUCB from typical HUCB collections. 1 Therefore, successful in vitro expansion of HUCB-hematopoietic stem/progenitor cells, which can restore a recipient's hematopoiesis, is expected to result in wide applicability of HUCB for clinical purposes including the treatment of adults.
Many researchers have tried to expand hematopoietic stem/progenitor cells contained in HUCB, peripheral blood, bone marrow and fetal liver. 1, [6] [7] [8] Most of these studies involved the amplification of CD34 ϩ cells by means of a comCorrespondence: T Tsuji, Pharmaceutical Frontier Research Laboratories, JT Inc., 1-13-2 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan; Fax: ϩ81-45-786-7692 Received 24 July 1998; accepted 27 May 1999 bination of cytokines. Although the numbers of total hematopoietic cells and colony-forming units increased dramatically with the cytokine combination protocol, the number of CD34 ϩ cells, which are capable of multiple differentiation ability, decreased. 7 The proliferation and differentiation of hematopoietic stem/progenitor cells is thought to be regulated by cellular interactions between hematopoietic cells and stromal cells comprising the hematopoietic microenvironment in hematopoietic organs. 9 These cellular interactions are mediated by direct cell-to-cell interactions via cell contact, and also by humoral factors produced by stromal cells. [10] [11] [12] Long-term cultures in vitro have demonstrated the important roles of the maintenance, self-renewal, proliferation and differentiation of stem/progenitor cells. However, in in vitro cultures in the absence of stromal cells, the proliferation and differentiation of stem/progenitor cells is dependent only on the presence of cytokines. 13, 14 Recently, we developed a xenogenic coculture system involving HUCB-CD34 ϩ cells and a murine stromal cell line, HESS-5 cells, in the presence of human cytokines such as recombinant human interleukin-3 (rh-IL-3), stem cell factor (SCF), granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF) and erythropoietin (EPO). 15 The most potent combination of cytokines in this coculture system for increasing the number of CD34 highϩ cells and CFUs was recombinant human interleukin-3 (rh-IL-3) and stem cell factor (SCF). The proliferation of CD34 highϩ and primitive progenitor cells was calculated by FACS analysis and was expressed in terms of the number of CD34 highϩ and CD34 highϩ CD38 low/Ϫ cells, which have been identified as among the most primitive progenitor cells, and high-proliferative potential colony-forming cells (HPP-CFCs). HPP-CFCs in human and murine bone marrow were reported to be earlier in the stem/progenitor cell hierarchy than CFU-GEMM, and a counterpart of murine HPP-CFCs has been detected in human bone marrow, umbilical cord blood and fetal liver. [16] [17] [18] In the present study, we characterized the re-isolated CD34 ϩ and CD34 highϩ CD38 low/Ϫ cells after in vitro expansion in a large-scale xenogenic coculture system. The CD34 ϩ CD38 Ϫ immunophenotype defines a primitive subpopulation of hematopoietic stem/progenitor cells in hematopoietic organs. [19] [20] [21] [22] The cell surface markers, colony-forming ability and cell-cycle status of the re-isolated CD34 ϩ cells after in vitro expansion in this xenogenic coculture system are described. We compared the capability for secondary expansion and differentiation of re-isolated CD34 highϩ CD38
low/Ϫ cells into B progenitor cells after in vitro expansion with that of freshly isolated CD34 highϩ CD38 low/Ϫ cells. We also performed quantitation analysis on long-term culture (LTC)-initiating cells and clonogenic B progenitor cells in freshly isolated and re-isolated CD34 highϩ CD38 low/Ϫ cells using limiting dilution analysis. Furthermore, long-term reconstitution ability of the re-isolated CD34 highϩ CD38 low/Ϫ cells in non-obese diabetic mice with severe combined immunodeficiency disease (NOD/SCID mice) was analyzed.
Materials and methods

Cytokines and monoclonal antibodies
Purified recombinant human stem cell factor (rh-SCF) was purchased from R&D Systems (Minneapolis, MN, USA). Recombinant human interleukin-3 (rh-IL-3) was obtained from Genzyme (Cambridge, MA, USA). Monoclonal antibodies (mAbs) were used for cell-surface marker analysis by flow cytometry: fluorescein isothiocyanate (FITC)-conjugated anti-CD34 mAb (␣CD34; clone HPCA-2) was obtained from Becton Dickinson Immunocytometry Systems (San Jose, CA, USA), and R-phycoerythrin (PE)-conjugated ␣CD13 (clone WM-15), ␣CD33 (clone WM-53), ␣CD38 (clone HIT2), ␣CD45RA (clone HI100), ␣CD10 (clone HI10a), ␣CD19 (clone HIB19), ␣CD5 (clone UCHT2), and ␣CD2 (clone RPA-2.10) mAbs were purchased from Pharmingen (San Diego, CA, USA).
Murine stromal cells and their culture
The murine stromal cell line was established from bone marrow of C3H/HeN mice, and its hematopoietic supportive ability was analyzed by means of in vitro long-term cultures as described previously. 23 HESS-5 cells were maintained in alpha-minimal essential medium (␣-MEM; Nikken Bio Medical Laboratory, Kyoto, Japan) supplemented with 10% (v/v) horse serum (HS; Nichimen America, Los Angeles, CA, USA).
Collection and preparation of CD34
ϩ cells from HUCB and in vitro expanded cells HUCB was obtained on full-term deliveries, and under the guidelines established by the Review Boards of Tokyo Senbai Hospital and the Pharmaceutical Frontier Research Laboratories, JT Inc. Blood was collected in sterile tubes containing 20 U/ml heparin from the umbilical cord vein at the placental end by needle aspiration while the placenta remained in situ.
Low-density cells (Ͻ1.077 g/ml), CD34 ϩ and CD34 Ϫ cells were isolated according to the instruction manuals and as described previously. 15, 24 Cells after in vitro expansion were also subjected to the same separation procedure as for CD34 ϩ cells.
Xenogenic coculture of murine stromal cells and HUCB CD34
ϩ cells
HUCB-CD34
ϩ cells (1 ϫ 10 5 cells/ml) were cocultured with or without a confluent layer of the murine stromal cell line, HESS-5 cells, in 30 ml of Myelocult H5100 (␣-MEM supplemented with 12.5% HS, 12.5% fetal calf serum (FCS), and 10 Ϫ4 m 2-mercaptoethanol; Stem Cell Technologies, Vancouver, British Columbia, Canada) in a 75 cm 2 culture flask (Falcon, Lincoln Park, NJ, USA) with rh-IL-3 and rh-SCF. 15, 25 After 10 days culture, the cells were harvested by pipetting, filtration through a nylon mesh and then centrifugation. These cells were subjected to immunofluorescence staining, and cell surface markers were analyzed by flow cytometry, and also colony formation ability was analyzed by semi-solid methylcellulose assaying. 
Semisolid methylcellulose assay
The assay for the detection of hematopoietic progenitor cells was performed in a complete pretested mixture, Methocult GF H4434V (Stem Cell Technologies), comprising 0.9% Iscove's methylcellulose, 30% FCS, 1% BSA, 10 Ϫ4 m 2-ME, 2 mm lglutamine, 3 U/ml erythropoietin, 50 ng/ml rh-SCF, 10 ng/ml rh-GM-CSF, 10 ng/ml rh-G-CSF and 20 ng/ml rh-IL-3, as described previously. 15, 16, 26 The cells were incubated at 37°C under a humidified atmosphere of 5% CO 2 for 28 days, and then assayed for colony formation as to CFU-GM, HPP-CFCs and erythroid colonies including BFU-E and CFU-GEMM. 15, 16 Cell cycle analysis
Mononuclear cells and CD34
ϩ cells in HUCB, and cultured cells after expansion in the xenogenic culture system were subjected to cell cycle analysis. The repopulated CD34 ϩ cells were re-isolated from total hematopoietic cells after expansion as described above. These cells were stained using a Cycle TEST PLUS DNA Reagent Kit (Becton Dickinson) according to the instruction manual. Cell samples were analyzed with a FACSort flow cytometer (Becton Dickinson) calibrated with a DNA Quality Control Kit (Becton Dickinson) using the nuclei of chicken erythrocytes and thymocytes. The percentages of cells in the G 0 /G 1 -, S-and G 2 /M-phases of the cell cycle were determined using CellFIT software (Becton Dickinson). ϩ cells after in vitro expansion were cultured in this xenogenic coculture system in combination with rh-IL-3 and rh-SCF as described above.
Comparison of
On the other hand, the B progenitor culture reported by Rawlings et al 27 was modified and performed using HESS-5 cells. Briefly, 3 ϫ 10 3 cells/well of a 12-well culture plate of the sorted CD34 highϩ CD38 low/Ϫ cells were plated on a confluent layer of HESS-5 cells in 2 ml of RPMI-1640 medium (Nikken Bio Medical Laboratory) supplemented with 3% defined FCS (GIBCO-BRL, Rockville, MD, USA), 5 ϫ 10 −5 m 2-mercaptoethanol and 50 ng/ml of rh-flk-2/flt-3 ligand (PeproTech EC, London, UK). At weekly intervals, half of the medium was changed. For analysis after 3 weeks in culture, the cultured cells were harvested, and then stained with FITC-␣CD19 and PE-␣CD10 mAbs. Quantitation of B progenitor cells was performed by limiting dilution analysis. For limiting dilution experiments, the CD34 highϩ CD38 low/Ϫ cells sorted HUCB or the expanded cells were seeded on to the confluent layer of HESS-5 cells at the concentration of 2-200 cells per well with 24 replicates in 150 l of the same medium as described above. After 3 weeks in culture, the frequency of the B-progenitor cells in these populations was calculated by Poisson statistics and weighted mean method.
28,29
Quantitation of LTC-initiating cells in CD34 highϩ CD38 low/Ϫ cells sorted from HUCB and the in vitro expanded cells by limiting dilution analysis
To determine the frequency of LTC-initiating cells by limiting dilution analysis, we developed the long-term culture method on HESS-5 cells for 5 weeks. Confluent layers of HESS-5 cells were established on 96-well type plate (Falcon), and then the CD34 highϩ CD38 low/Ϫ cells sorted from HUCB and the in vitro expanded cells were seeded on the layer at the range of 2-200 cells per well with 24 replicates in Myelocult H5100 (Stem Cell Technologies). At weekly intervals, half of the culture medium was changed for fresh medium. After 5 weeks in culture, wells were assayed for CFU-C in methylcellulose culture as described above and colonies were counted after 2 weeks. Individual wells were scored as a positive if at least one colony was detected. The frequency of LTC-initiating cells in the seeded population was calculated by Poisson statistics and the weighted mean method.
28,29
Transplantation of CD34 highϩ CD38 low/Ϫ cells into immune-deficient mice
Sublethally irradiated (350 cGy) 8-week-old NOD/LtSzscid/scid (NOD/SCID) mice, which were obtained from Clea Japan (Tokyo, Japan), received transplantation by tail-vein injection as described in previous reports. 
Results
Expansion of HUCB-CD34 ϩ cells in a xenogenic coculture system
Recently, we reported a xenogenic coculture system involving HUCB-CD34 ϩ cells and murine hematopoietic-supportive stromal cells, HESS-5 cells. 15 The optimal cytokine combination for the proliferation of CD34 ϩ cells and HPP-CFCs was rh-IL-3 and rh-SCF in the coculture system. To characterize the re-isolated CD34 ϩ cells and CD34 highϩ CD38 low/Ϫ cells after the expansion, we performed on a practical large scale of 75 cm 2 . The FACS profiles on staining with ␣CD34-FITC and ␣CD38-PE are shown in Figure 1 .
When HUCB-CD34 ϩ cells were cultured on stimulation with rh-IL-3 and rh-SCF in the absence of HESS-5 cells, the total number of hematopoietic cells greatly increased to 169.7 ± 4.0-fold that of starting cells. However, the content of CD34 highϩ cells among total hematopoietic cells stimulated with rh-IL-3 and rh-SCF dramatically decreased (2.0%), and the calculated number of CD34 highϩ cells slightly increased (5.5 ± 1.6-fold). In contrast, the number of total hematopoietic cells and CD34 highϩ cells dramatically increased 396.4 ± 82.5-and 102.1 ± 23.1-fold, respectively, in the xenogenic coculture system in combination with rh-IL-3 and rh-SCF. Under these culture conditions, surprisingly, a very primitive stem/progenitor population, CD34
highϩ CD38 low/Ϫ cells, was clearly detected (1.0%).
We also examined colony formation assay after the in vitro expansion as described above. In the presence of rh-IL-3 and rh-SCF without HESS-5 cells, only myeloid progenitor cells (CFU-GM) dramatically increased (180 ± 47-fold), small HPP-CFC and erythroid progenitor cells only slightly increasing (4.9-fold and 5.7-fold). Large HPP-CFC were not detected under these assay conditions. Under the xenogenic coculture condition in combination with rh-IL-3 and rh-SCF, on the other hand, the number of progenitor cells dramatically increased. The large and small HPP-CFC proliferated 65.6-fold and 161.4-fold, respectively. The number of CFU-GM increased to 734.2-fold, ie more than under the culture conditions without the stromal cells (244.9-fold). An increase in the number of erythroid colonies, including BFU-E and CFU-GEMM, was observed under these culture conditions (12.4-fold).
Characterization of the expanded CD34 ϩ cells in the xenogenic coculture system in combination with rh-IL-3 and rh-SCF
To characterize the expanded CD34 ϩ cells, CD34 ϩ cells were re-isolated from the total expanded cells, which were cultured with stimulation with rh-IL-3 and rh-SCF in the xenogenic coculture system as described above, by magnetic cell sorting. After in vitro expansion in this system, the re-isolated CD34 The efficiency of colony formation of the freshly isolated and re-isolated CD34 ϩ cells was the same (35.4% and 34.2%, respectively: Table 1 ). Although the number of small HPP-CFC among the re-isolated CD34 ϩ cells per 10 5 cells was the same as that among the freshly isolated HUCB-CD34 ϩ cells, the content of large HPP-CFC and erythroid colonies in the reisolated CD34 ϩ cells after in vitro expansion was decreased to 58.9% and 7.7%, respectively, that of HUCB-CD34 ϩ cells. In contrast, the number of CFU-GM of the re-isolated CD34 ϩ cells increased to 2.9-fold that of the starting HUCB-CD34 ϩ cells.
The FACS profiles of the freshly isolated HUCB-CD34 ϩ cells and re-isolated CD34 ϩ cells are shown in Figure 2 . The size and density of the re-isolated CD34 ϩ cells were greater than those of freshly isolated HUCB-CD34 ϩ cells. The results are expressed as mean numbers of colonies per 10 2 CD34 + cells ± s.e., isolated from human umbilical cord blood and in vitro expanded CD34
+ cells in the xenogenic coculture system in combination with rh-IL-3 (20 ng/ml) and rh-SCF (50 ng/ml) as described under Materials and methods. The colony formation assay was performed at the density of 100-300 cells/dish, 35 mm in diameter, and in triplicate. These results are representative of four independent experiments. that of the freshly isolated CD34 ϩ cells (each P Ͻ 0.01; Student's t-test). The percentage of the CD34 highϩ CD38 low/Ϫ cell population among the re-isolated CD34 ϩ cells decreased to 65.1% that of HUCB-CD34 ϩ cells (P Ͻ 0.05; Student's t-test). In contrast, the CD34 ϩ CD13 low/Ϫ cell population among HUCB-CD34 ϩ cells increased on expansion. The expression of CD10 and CD19 did not change before or after expansion. On examination of the expression of CD2 and CD5, surprisingly, CD34
ϩ CD2 ϩ and CD34 ϩ CD5 ϩ cell populations were clearly detected among the re-isolated CD34 ϩ cells (8.7% and 0.6%, respectively).
Cell cycle analysis of HUCB-CD34
ϩ cells and expanded CD34
To confirm the proliferation of re-isolated CD34 ϩ cells stimulated with rh-IL-3 and rh-SCF in the xenogenic coculture system, we next performed cell cycle analysis of the CD34 ϩ cells (Figure 3) . Although freshly isolated HUCB-mononuclear cells and CD34 ϩ cells, 96.8% and 97.5%, respectively, were in the G 0 /G 1 phase of the cell cycle, CD34
ϩ cells re-isolated from the total hematopoietic cells of an in vitro expansion culture with stimulation with rh-IL-3 and rh-SCF, and coculturing with HESS-5 cells, which were the culture conditions for the selfrenewal of CD34 ϩ cells, were found to pass to the cycling phase (41.6%) from the G 0 /G 1 phase (58.4%), like the total hematopoietic cells.
Comparison of the characteristics of the CD34 highϩ CD38 low/Ϫ cell population between before and after in vitro expansion
The primitive progenitor cells are known to be enriched in the CD34 ϩ CD38 Ϫ subpopulation. [24] [25] [26] [27] After expansion in the Generation of CD34 high؉ CD38 low/؊ cells in a xenogenic coculture system T Tsuji et al 1413
Figure 2
Phenotypic characterization of freshly isolated HUCB-CD34 + cells and re-isolated CD34 + cells after in vitro expansion, with doublestaining with ␣CD34-FITC and ␣CD33-PE, ␣CD38-PE, ␣CD13-PE, ␣CD45RA-PE, ␣CD10-PE, ␣CD19-PE, ␣CD5-PE or ␣CD2-PE. Region R1 was used for analysis of cell surface marker expression on the cells. The percentages of cells expressing high and low/undetectable levels of the CD34, CD33, CD38, CD13, CD45RA, CD10, CD19, CD5 and CD2 antigens are given in the upper and lower quadrants of each histogram. These results are expressed as the mean values for triplicate wells and representative of four independent experiments. xenogenic coculture system, a minor primitive CD34 highϩ CD38 low/Ϫ cell population was clearly detected. To determine whether or not this subpopulation after expansion possesses the characteristics of primitive stem/progenitor cells, we performed a secondary culture on HESS-5 cells and a B progenitor culture of this subpopulation in vitro, and then the abilities of CD34 highϩ CD38 low/Ϫ cells after the in vitro expansion were compared with those of the subpopulation in HUCB-CD34 ϩ cells. The freshly and re-isolated CD34 highϩ CD38 low/Ϫ cell populations derived from HUCB-CD34 ϩ cells and CD34 ϩ cells after in vitro expansion, respectively, are shown in Figure 4a . The re-isolated CD34 highϩ CD38 low/Ϫ cells were subjected to the secondary xenogenic coculture on a confluent layer of HESS-5 cells in combination with rh-IL-3 and rh-SCF. After 10 days, the contents of CD34 highϩ cells in the total hematopoietic cells among the freshly isolated and re-isolated CD34 highϩ CD38 low/Ϫ cells were 16.6 and 12.4%, respectively, and no essential differences were observed between these two FACS profiles (Figure 4b ). When these cells were cultured in the absence of HESS-5 cells with rh-IL-3 and rh-SCF, the CD34 highϩ cells dramatically decreased, like the culture of the freshly isolated HUCB-CD34 ϩ cells, as described above. The numbers of total hematopoietic cells and CD34 highϩ cells among the freshly isolated and re-isolated CD34 highϩ CD38 low/Ϫ cells are shown in Table 2 .
Next, we examined the production of B lymphoid progenitor cells from these subpopulations in vitro reported by Rawlings et al 27 except for the cocultured stromal cells. We cultured fresh and re-isolated CD34 highϩ CD38 low/Ϫ cells in the + cells were stimulated with rh-IL-3 and rh-SCF in the xenogenic coculture system, and then CD34 + cells were re-isolated from the total hematopoietic cells as described under Materials and methods. The cells were stained with propidium iodide and then analyzed by FACS. The contents of cells in the G 0 /G 1 -, S-and G 2 M-phases of the cell cycle were determined using CellFIT software on a FACSort (Becton Dickinson). The percentage in each phase is expressed as the mean value for three independent experiments, and is given in each histogram. presence of HESS-5 cells because HESS-5 cells also stimulate the production of B progenitor cells in the condition. The harvested cells were small and showed low-density and they were typically lymphoid ( Figure 5) . Furthermore, almost all the cells were CD19CD10-double positive B progenitor ones ( Figure 5 ), and these cells exhibited no staining with myeloid lineage-specific markers such as CD13 and CD33 (data not shown). The numbers of the cells increased to 114.7-and 101.7-fold those of starting cells, respectively ( Table 3 ). The frequency of clonogenic B progenitor cells in the freshly isolated and the re-isolated CD34 highϩ CD38 low/Ϫ cells was calculated to be 1 per 41 and 19.5 cells, respectively ( Figure 6 ). Taken together, these results indicate that the re-isolated CD34 highϩ CD38 low/Ϫ cells after in vitro expansion have the same abilities as to proliferation and differentiation into myeloid and B lymphoid cells as the freshly isolated CD34 highϩ CD38 low/Ϫ cells, and possess the characteristics of primitive progenitor cells.
Quantitation of LTC-initiating cells in CD34 highϩ CD38 low/Ϫ cells isolated from HUCB and the in vitro expanded cells by limiting dilution analysis
To determine whether the sorted CD34 highϩ CD38
low/Ϫ cells have the ability to sustain long-term hematopoiesis, the fre- 
Reconstitution of immuno-deficient mice by injection of re-isolated CD34 highϩ CD38 low/Ϫ cells after xenogenic coculture
Re-isolated CD34 highϩ CD38 low/Ϫ cells after xenogenic coculture possess long-term reconstitution ability in immuno-
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Figure 4
Flow cytometric analysis of the freshly isolated and the re-isolated CD34 low/− cells derived from the HUCB-CD34 + cells and re-isolated CD34 + cells after expansion were cultured on HESS-5 cells in the presence of rh-IL-3 (20 ng/ml) and rh-SCF (50 ng/ml) for 10 days as described under Materials and methods. The cells was harvested and the numbers of total hematopoietic cells determined. The number of CD34 high+ cells were calculated from the total hematopoietic cell number and the percentage of CD34 high+ cells by FACS analysis. The results are expressed as the mean number per well of 12-well culture plate ± s.e., and are representative of three independent experiments. deficient NOD/SCID mice. Purified 2 ϫ 10 5 cells CD34 highϩ CD38 low/Ϫ cells isolated from HUCB and total expanded cells after xenogenic coculture were transplanted into five NOD/SCID mice. Twelve weeks after transplantation, human CD45 ϩ cells were detected in all transplanted mice and in the bone marrow of both NOD/SCID mice transplanted with freshly isolated and re-isolated CD34 highϩ CD38 low/Ϫ cells (Table 4) . No significant differences were observed in the percentages of chimerism for CD45 ϩ cell in bone marrow between the freshly isolated and re-isolated CD34 highϩ CD38
low/Ϫ
cells. A typical histogram of the expression of human CD45
ϩ cells is shown in Figure 8a . Human CD45 ϩ cells were contained at above 70% of total bone marrow cells in NOD/SCID mice transplanted with the re-isolated CD34 highϩ CD38 low/Ϫ cells. Human CD34 ϩ cells were clearly detected in bone marrow cells in NOD/SCID mice (Figure 8b ). CD38 ϩ cells, which were expressed on the cell surface of mature myeloid and lymphoid cells, were also detected in the bone marrow cells (Figure 8b) , and the transplanted cells were capable of multilineage differentiation into myeloid (CD13 ϩ ) and B lymphoid cells (CD19 ϩ ) in NOD/SCID mice (data not shown).
Discussion
Some researchers have reported analysis of the proliferation of human hematopoietic cells using a xenogenic coculture system. 19, 20 The number of clonogenic progenitor cells increased 3-to 10-fold on 5-10 weeks coculture, and the clonogenic output on long-term culture of CD34 ϩ+ /CD38 Ϫ cells on murine stromal cells was greater than that on human Generation of CD34 high؉ CD38 low/؊ cells in a xenogenic coculture system T Tsuji et al
Figure 5
Phenotypic characterization of total hematopoietic cells after B progenitor culture of (a) freshly-isolated and (b) re-isolated CD34 high+ CD38
low/− cells, with double staining with FITC-␣CD19 and PE-␣CD10 mAbs. The specified lymphoid gate was set on the forward and side scatter histogram (Region R1), and used for analysis of the expression of cell surface markers on the cells. The cells (3 × 10 3 cells/well) were cultured on HESS-5 cells in 2 ml of RPMI-1640 medium supplemented with 3% FCS, 5 × 10 −5 M 2-mercaptoethanol and 50 ng/ml flk-2/flt-3 ligand as described under Materials and methods. After 3 weeks culture, the cells were counted and analyzed with a flow cytometer. The small and low-density CD19 +
CD10
+ cell population was calculated as B progenitor cells. The reproducibility of these results was confirmed by four independent experiments. stromal cells. 19 However, this expansion needs a long culture period and it seems to be difficult to put this method into practical use for clinical applications. Recently, we developed a short-term xenogenic coculture system involving HUCB-CD34 ϩ cells and HESS-5 cells. 15 With this xenogenic coculture system, the combination of rh-IL-3 and rh-SCF was the most effective for the proliferation of CD34 highϩ and primitive progenitor cells among a wide variety of combinations of human cytokines, such as rh-IL-3, rh-SCF, rh-G-CSF, rh-GM-CSF, and h-EPO. 15 HESS-5 cells strongly promoted the proliferation of HUCB-CD34 ϩ cells in combination with rh-IL-3 and rh-SCF and is necessary to expand CD34 ϩ cells in vitro. In the present study, we characterized and compared in detail the potencies as hematopoietic progenitor cells of the re-isolated CD34 ϩ and CD34 highϩ CD38 low/Ϫ cells with freshly isolated ones. Previously, the cell cycle of total hematopoietic cells amplified from CD34
ϩ cells with a combination of cytokines was reported by several groups. 33, 34 However, these groups did not examine the re-isolated CD34 ϩ cells after expansion. We performed cell cycle analysis of both total hematopoietic cells and re-isolated CD34 ϩ cells. Although almost all the freshly isolated HUCB-CD34 ϩ cells existed in the G 0 /G 1 phase of the cell cycle (97.6%), the re-isolated CD34 ϩ cells after expansion had exited from the quiescent phase, and many cells had entered the S-and G 2 /M phases (41.6%), as judged on cell cycle analysis. Moreover, how to get CD34 ϩ cells to enter the growth phase for successful genetic modification of hematopoietic cells with a retroviral vector is a difficult problem. 35 This system may be an effective means of genetic modification of progenitor cells with a retroviral vector.
To determine whether or not the CD34 highϩ CD38 low/Ϫ cell population after in vitro expansion has the characteristics of functionally immature cells, like the freshly isolated 
CD34
highϩ CD38 25 This assay appears to be useful since many of the LTC-initiating cells identified in human marrow share unique and rare phenotype characteristics of transplantable murine repopulating cells. 36, 37 As judged from the results by limiting dilution assay, the frequencies of LTC-initiating cells in the freshly isolated and the re-isolated CD34 highϩ CD38 Furthermore, SCID repopulating cells (SRCs) were identified and found to be capable of long-term and multilineage reconstitution of human hematopoiesis in NOD/SCID mice. [30] [31] [32] As judged from gene marking analysis by retroviral infection, SRCs were primitive and distinct from most CFCs and LTCICs. 30 SRCs were highly enriched in the CD34 ϩ CD38 Ϫ cell fractions. 31 The re-isolated CD34 highϩ CD38 low/Ϫ cells possessed multilineage repopulating ability in NOD/SCID mice and no significant differences were seen in the numbers of human CD45
ϩ cells between bone marrow cells after transplantation with the freshly and re-isolated CD34 highϩ CD38 low/Ϫ cells. These results strongly suggest that the CD34 highϩ CD38 low/Ϫ cells generated in this xenogenic coculture system possess the characteristics of hematopoietic primitive progenitor cells.
This xenogenic coculture system should be a useful basic method to provide valuable information on the regulation mechanisms of stem/progenitor cells and the evaluation of cisactivities of various kinds of retroviral vectors for human hematopoietic cells. This coculture would have the potential clinical application for expansion of hematopoietic cells and gene therapy. For the clinical purpose, this coculture system is suboptimal from the viewpoint of biosafety. We are making efforts to establish an indirect coculture system between human cells and murine stromal cells using microporous membrane 15 and a serum-free defined medium. After these efforts, the xenogenic coculture system would be worthy of consideration for the clinical application of transplantation, gene therapy and the development of hematopoietic stem/progenitor banking. Further studies on the regulatory molecule for the proliferation of primitive progenitor cells on HESS-5 cells would also provide valuable information on the role of hematopoietic-supportive stromal cells in the hematopoietic microenvironment. 
